94 related articles for article (PubMed ID: 19242058)
21. Genetic mutations in thyroid carcinoma.
Taccaliti A; Boscaro M
Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
[TBL] [Abstract][Full Text] [Related]
22. HLA-C locus alleles may modulate the clinical expression of psoriatic arthritis.
Queiro R; Gonzalez S; López-Larrea C; Alperi M; Sarasqueta C; Riestra JL; Ballina J
Arthritis Res Ther; 2006; 8(6):R185. PubMed ID: 17166285
[TBL] [Abstract][Full Text] [Related]
23. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B
J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364
[TBL] [Abstract][Full Text] [Related]
24. Association between HLA-DRB1*01 and HLA-Cw*08 and outcome following HTLV-I infection.
Rafatpanah H; Pravica V; Faridhosseini R; Tabatabaei A; Ollier W; Poulton K; Thomson W; Hutchinson I
Iran J Immunol; 2007 Jun; 4(2):94-100. PubMed ID: 17652849
[TBL] [Abstract][Full Text] [Related]
25. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
[TBL] [Abstract][Full Text] [Related]
26. HLA-C genes and susceptibility to type 1 autoimmune hepatitis.
Strettell MD; Thomson LJ; Donaldson PT; Bunce M; O'Neill CM; Williams R
Hepatology; 1997 Oct; 26(4):1023-6. PubMed ID: 9328330
[TBL] [Abstract][Full Text] [Related]
27. The possible role of classical human leukocyte antigens in recurrent miscarriage.
Christiansen OB
Am J Reprod Immunol; 1999 Aug; 42(2):110-5. PubMed ID: 10476693
[TBL] [Abstract][Full Text] [Related]
28. TP53 codon 72 polymorphism in radiation-associated human papillary thyroid cancer.
Rogounovitch TI; Saenko VA; Ashizawa K; Sedliarou IA; Namba H; Abrosimov AY; Lushnikov EF; Roumiantsev PO; Konova MV; Petoukhova NS; Tchebotareva IV; Ivanov VK; Chekin SY; Bogdanova TI; Tronko MD; Tsyb AF; Thomas GA; Yamashita S
Oncol Rep; 2006 Apr; 15(4):949-56. PubMed ID: 16525684
[TBL] [Abstract][Full Text] [Related]
29. [A matched case-control study of papillary thyroid carcinoma].
Zhu QX; Bian JC; Shen Q; Tang HW; Zhang HW; Wu Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 May; 27(5):416-9. PubMed ID: 16981339
[TBL] [Abstract][Full Text] [Related]
30. HLA and thyroid carcinoma.
Ahuja S; Hoppe I; von Keyserlingk H; Ernst H
Exp Clin Endocrinol; 1992; 99(3):134-6. PubMed ID: 1526261
[TBL] [Abstract][Full Text] [Related]
31. [HLA and thyroid cancer].
Dralle H; Robin-Winn M; Reilmann L; Laue A; Török M
Klin Wochenschr; 1986 Jun; 64(11):522-5. PubMed ID: 3459939
[TBL] [Abstract][Full Text] [Related]
32. [Familial occurrence of differentiated, non-medullary thyroid carcinoma].
Ozaki O; Ito K; Eto M; Kobayashi K; Suzuki A; Manabe Y; Hosoda Y
Nihon Gan Chiryo Gakkai Shi; 1987 May; 22(4):809-17. PubMed ID: 3668355
[No Abstract] [Full Text] [Related]
33. Strong association between an HLA-DR antigen and thyroid carcinoma.
Panza N; Del Vecchio L; Maio M; De Felice M; Lombardi G; Minozzi M; Zappacosta S
Tissue Antigens; 1982 Aug; 20(2):155-8. PubMed ID: 6814009
[TBL] [Abstract][Full Text] [Related]
34. HLA-G 3' untranslated region polymorphic sites associated with increased HLA-G production are more frequent in patients exhibiting differentiated thyroid tumours.
de Figueiredo-Feitosa NL; Martelli Palomino G; Cilião Alves DC; Mendes Junior CT; Donadi EA; Maciel LM
Clin Endocrinol (Oxf); 2017 Apr; 86(4):597-605. PubMed ID: 27914217
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-10 gene polymorphism in patients with papillary thyroid cancer in Turkish population.
Erdogan M; Karadeniz M; Ozbek M; Ozgen AG; Berdeli A
J Endocrinol Invest; 2008 Sep; 31(9):750-4. PubMed ID: 18997484
[TBL] [Abstract][Full Text] [Related]
36. Association study of integrins beta 1 and beta 2 gene polymorphism and papillary thyroid cancer.
Eun YG; Kim SK; Chung JH; Kwon KH
Am J Surg; 2013 Jun; 205(6):631-5. PubMed ID: 23388428
[TBL] [Abstract][Full Text] [Related]
37. rs965513 polymorphism as a common risk marker is associated with papillary thyroid cancer.
Wang F; Yan D; Ji X; Han J; Chen M; Qiao H; Zhang S
Oncotarget; 2016 Jul; 7(27):41336-41345. PubMed ID: 27191655
[TBL] [Abstract][Full Text] [Related]
38. Weak or absent evidence for the association of HLA-DR antigens with risk of thyroid carcinoma: a meta-analysis of observational studies.
Kamdi AS; Kandavalli NB; Emusu D; Jain N; Mamtani M; Porterfield JR
Tissue Antigens; 2011 Nov; 78(5):382-9. PubMed ID: 21812765
[TBL] [Abstract][Full Text] [Related]
39. Parental cancer and risk of papillary and follicular thyroid carcinoma.
Galanti MR; Ekbom A; Grimelius L; Yuen J
Br J Cancer; 1997; 75(3):451-6. PubMed ID: 9020497
[TBL] [Abstract][Full Text] [Related]
40. Role of PTPRJ genotype in papillary thyroid carcinoma risk.
Iuliano R; Palmieri D; He H; Iervolino A; Borbone E; Pallante P; Cianflone A; Nagy R; Alder H; Calin GA; Trapasso F; Giordano C; Croce CM; de la Chapelle A; Fusco A
Endocr Relat Cancer; 2010 Dec; 17(4):1001-6. PubMed ID: 20823296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
